Professional Planning’s iShares Biotechnology ETF IBB Stock Holding History

Professional Planning’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$336K	Hold	2,081	–	–	0.16%	93
2021 Q2	$340K	Sell	2,081 -234	-10%	-$36K	0.16%	95
2021 Q1	$348K	Buy	2,315 +88	+4%	+$14K	0.17%	86
2020 Q4	$337K	Buy	+2,227	New	+$318K	0.14%	93
2020 Q3	–	Sell	-1,513	Closed	-$207K	–	58
2020 Q2	$207K	Buy	+1,513	New	+$193K	0.11%	110

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Professional Planning's IBB Position: Q3 2021 in Review

Professional Planning held its iShares Biotechnology ETF (IBB) position steady in Q3 2021 at 2,081 shares worth $336K. The position accounts for 0.16% of the portfolio, ranked #93.

Professional Planning first reported a position in IBB in Q2 2020 and has held it in 5 quarters since. The position peaked at $348K in Q1 2021. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

Professional Planning held 2,081 shares of iShares Biotechnology ETF worth $336K as of Q3 2021.
Professional Planning left its iShares Biotechnology ETF share count unchanged in Q3 2021.
iShares Biotechnology ETF made up 0.16% of Professional Planning's portfolio in Q3 2021, its #93 holding.
Professional Planning first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 5 quarters since.
Professional Planning's iShares Biotechnology ETF position peaked at $348K in Q1 2021.
855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Professional Planning's 13F filing for Q3 2021, filed 15 Nov 2021.